SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

SMTL ID : 4aqc.2 (1 other biounit)

Triazolopyridine-based Inhibitor of Janus Kinase 2

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.90 Å
Oligo State
monomer
Ligands
1 x 88A: 8-(4-methylsulfonylphenyl)-N-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine(Non-covalent)
4 x SO4: SULFATE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Dugan, B.J. et al., A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-A]Pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of Cep-33779. J.Med.Chem. (2012)
Release Date
2012-04-25
Peptides
TYROSINE-PROTEIN KINASE JAK2: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
B

TYROSINE-PROTEIN KINASE JAK2

Related Entries With Identical Sequence

4aqc.1